Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Buy
62
CCAP Quote, Financials, Valuation and Earnings
Last price:
$14.56
Seasonality move
:
1.61%
Day range:
$14.30 - $14.58
52-week range:
$13.03 - $20.19
Dividend yield:
11.54%
P/E ratio:
14.99x
P/S ratio:
3.46x
P/B ratio:
0.75x
Volume:
168.4K
Avg. volume:
216.6K
1-year change:
-26.45%
Market cap:
$538.6M
Revenue:
$194.8M
EPS (TTM):
$0.97
Analysts' Opinion
-
Consensus RatingCrescent Capital BDC, Inc. has received a consensus rating of Buy. The company's average rating is a Buy based on 3 Buy ratings, 1 Hold rating, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $16.08, Crescent Capital BDC, Inc. has an estimated upside of 11.77% from its current price of $14.57.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $14.00 representing 100% downside risk from its current price of $14.57.
Fair Value
-
According to the consensus of 4 analysts, Crescent Capital BDC, Inc. has 11.77% upside to fair value with a price target of $16.08 per share.
CCAP vs. S&P 500
-
Over the past 5 trading days, Crescent Capital BDC, Inc. has underperformed the S&P 500 by -4.4% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Crescent Capital BDC, Inc. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Crescent Capital BDC, Inc. revenues have been falling on a year-over-year basis for 4 quarters in a row. In the most recent quarter Crescent Capital BDC, Inc. reported revenues of $36.4M.
Earnings Growth
-
Crescent Capital BDC, Inc. earnings have been falling on a year-over-year basis for 6 quarters in a row. In the most recent quarter Crescent Capital BDC, Inc. reported earnings per share of $0.19.
Enterprise value:
1.3B
EV / Invested capital:
0.82x
Price / LTM sales:
3.46x
EV / EBIT:
13.39x
EV / Revenue:
8.32x
PEG ratio (5yr expected):
0.11x
EV / Free cash flow:
26.07x
Price / Operating cash flow:
10.83x
Enterprise value / EBITDA:
13.39x
Gross Profit (TTM):
$121M
Return On Assets:
2.18%
Net Income Margin (TTM):
23.06%
Return On Equity:
4.93%
Return On Invested Capital:
2.24%
Operating Margin:
58.62%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Income Statement | ||||||
| Revenue | $162.8M | $195.7M | $156.2M | $55.3M | $36.4M | |
| Gross Profit | $129.9M | $156.4M | $121M | $45.4M | $27.8M | |
| Operating Income | $110.3M | $160.8M | $97M | $32M | $21.4M | |
| EBITDA | $110.3M | $160.8M | $97M | $32M | $21.4M | |
| Diluted EPS | $1.54 | $2.55 | $0.97 | $0.41 | $0.19 | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $42.4M | $30.5M | $48.8M | $121.4M | $124.1M | |
| Total Assets | $1.2B | $1.3B | $1.6B | $1.6B | $1.6B | |
| Current Liabilities | $26.1M | $25.8M | $32.5M | $34.7M | $32.2M | |
| Total Liabilities | $587M | $716.7M | $894.2M | $896.2M | $913.6M | |
| Total Equity | $596.2M | $622.6M | $730.3M | $748.8M | $714.1M | |
| Total Debt | $557.1M | $686.1M | $856.7M | $857.2M | $875.3M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $41.5M | $101M | $49.8M | $27.3M | $18.7M | |
| Cash From Investing | $58M | -$4.6M | -$642K | $19.6M | $12.1M | |
| Cash From Financing | -$98.9M | -$81.4M | -$58.7M | -$45.3M | -$29.1M | |
| Free Cash Flow | $41.5M | $101M | $49.8M | $27.3M | $18.7M | |
CCAP
Sector
Market Cap
$538.6M
$570M
Price % of 52-Week High
72.12%
92.18%
Dividend Yield
11.54%
1.57%
Shareholder Yield
13.56%
3.12%
1-Year Price Total Return
-26.77%
7.87%
Beta (5-Year)
0.559
0.478
Dividend yield:
11.54%
Annualized payout:
$2.04
Payout ratio:
219.21%
Growth streak:
0 years
Technicals
8-day SMA
Sell
Level
$14.78
200-day SMA
Sell
Level
$15.04
Bollinger Bands (100)
Sell
Level
13.9 - 15.36
Chaikin Money Flow
Sell
Level
-1.3M
20-day SMA
Sell
Level
$14.66
Relative Strength Index (RSI14)
Buy
Level
51.10
ADX Line
Sell
Level
22.46
Williams %R
Buy
Level
-96.319
50-day SMA
Buy
Level
$14.24
MACD (12, 26)
Buy
Level
0.16
25-day Aroon Oscillator
Buy
Level
68
On Balance Volume
Sell
Level
-1.8M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (0.6926)
Buy
CA Score
(Annual)
Level (-0.2602)
Buy
Beneish M-Score
(Annual)
Level (-3.3968)
Sell
Momentum Score
Level (3)
Sell
Ohlson Score
Level (0.6183)
Buy
Piotroski F Score
(Annual)
Level (7)
Buy
Quality Ratio Score
Level (4)
Buy
Fundamental Score
Level (7)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Crescent Capital BDC, Inc., a traded business development company, invests in middle market companies located in the United States. The fund focuses on companies operating across a broad range of sectors. It provides financing in the form of secured debt including first lien, second lien debt, unsecured debt, mezzanine subordinated debt and equity securities for buyout transactions. It acquires controlling interest.
Stock Forecast FAQ
In the current month, CCAP has received 3 Buy ratings 1 Hold ratings, and 0 Sell ratings. The CCAP average analyst price target in the past 3 months is $16.08.
-
Where Will Crescent Capital BDC, Inc. Stock Be In 1 Year?
According to analysts, the consensus estimate is that Crescent Capital BDC, Inc. share price will rise to $16.08 per share over the next 12 months.
-
What Do Analysts Say About Crescent Capital BDC, Inc.?
Analysts are divided on their view about Crescent Capital BDC, Inc. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Crescent Capital BDC, Inc. is a Sell and believe this share price will drop from its current level to $14.00.
-
What Is Crescent Capital BDC, Inc.'s Price Target?
The price target for Crescent Capital BDC, Inc. over the next 1-year time period is forecast to be $16.08 according to 4 Wall Street analysts, 3 of them rate the stock a Buy, 0 rate the stock a Sell, and 1 analyst rates the stock a Hold.
-
Is CCAP A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Crescent Capital BDC, Inc. is a Buy. 3 of 4 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of CCAP?
You can purchase shares of Crescent Capital BDC, Inc. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Crescent Capital BDC, Inc. shares.
-
What Is The Crescent Capital BDC, Inc. Share Price Today?
Crescent Capital BDC, Inc. was last trading at $14.56 per share. This represents the most recent stock quote for Crescent Capital BDC, Inc.. Yesterday, Crescent Capital BDC, Inc. closed at $14.57 per share.
-
How To Buy Crescent Capital BDC, Inc. Stock Online?
In order to purchase Crescent Capital BDC, Inc. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Get CCAP Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
CCAP
Sector
P/E ratio
14.99x
12.24x
PEG ratio
0.11x
0.31x
P/B ratio
0.75x
1.11x
Price / LTM sales
3.46x
1.84x
Growth Metrics
CCAP
Sector
Revenue growth
-34.14%
5.54%
Earnings growth
-53.5%
14.85%
Revenue (5-year growth)
33.24%
8.84%
Earnings forecast
$0.46
$0.62
Profitability
CCAP
Sector
Profitability FY 2024
$156M
--
Return on invested capital
2.24%
5.01%
Return on assets
2.18%
1.01%
Return on equity
4.93%
9.68%
Earnings Date
Last Earnings Date
Nov
12
Next Earnings Date
Feb
25
Estimated Next Earnings Date
Feb
11
Balance Sheet
CCAP
Sector
Total cash
$108.8M
$431.4M
Short term investments
--
$211.3M
Total assets
$1.7B
$3.1B
Long term debt
$875.3M
$79M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is SentinelOne Stock Undervalued?
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Is Broadcom Stock on Sale?
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Stock Ideas
Buy
59
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 64x
Buy
55
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
85
HUT alert for Dec 25
Hut 8 Corp. [HUT] is up 0.65% over the past day.
Buy
80
TVTX alert for Dec 25
Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.
Buy
63
GPCR alert for Dec 25
Structure Therapeutics, Inc. [GPCR] is down 2.36% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
